{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T01:57:06Z","timestamp":1764986226615,"version":"3.46.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ando.2025.102463","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T22:46:13Z","timestamp":1760222773000},"page":"102463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic factors and survival in gastroenteropancreatic neuroendocrine neoplasm: Real-world evidence from a South American Single-Center Cohort"],"prefix":"10.1016","volume":"86","author":[{"given":"Luisana","family":"Molina-Pimienta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s A.","family":"Cu\u00e9llar Cu\u00e9llar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireya","family":"Tapiero-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Romero-Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas O.","family":"Sanchez-Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2025.102463_bib0155","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/ajco.12498","article-title":"Epidemiological features of gastroenteropancreatic neuroendocrine tumors in Chengdu city with a population of 14 million based on data from a single institution","volume":"12","author":"Guo","year":"2016","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.ando.2025.102463_bib0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000080731","article-title":"Epidemiology of Neuroendocrine Tumours","volume":"80","author":"Taal","year":"2004","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ando.2025.102463_bib0165","doi-asserted-by":"crossref","first-page":"100510","DOI":"10.1016\/j.lanepe.2022.100510","article-title":"Incidence and survival of neuroendocrine neoplasia in England 1995-2018: a retrospective, population-based study","volume":"23","author":"White","year":"2022","journal-title":"Lancet Reg Heal Eur"},{"key":"10.1016\/j.ando.2025.102463_bib0170","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.31557\/APJCP.2018.19.12.3597","article-title":"Factors affecting survival in neuroendocrine tumors: a 15-year single center experience","volume":"19","author":"Sakin","year":"2018","journal-title":"Asian Pacific J Cancer Prev"},{"key":"10.1016\/j.ando.2025.102463_bib0175","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO classification of neuroendocrine neoplasms","volume":"33","author":"Rindi","year":"2022","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.ando.2025.102463_bib0180","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201cCarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 Cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ando.2025.102463_bib0185","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11912-021-01029-7","article-title":"incidence, and prevalence of neuroendocrine neoplasms: are there global differences?","volume":"23","author":"Das","year":"2021","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.ando.2025.102463_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2024.1424839","article-title":"Gastroenteropancreatic neuroendocrine neoplasms: epidemiology, genetics, and treatment","volume":"15","author":"Tan","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ando.2025.102463_bib0195","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000443171","article-title":"ENETS Consensus Guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors","volume":"103","author":"Falconi","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ando.2025.102463_bib0200","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1477-7819-4-35","article-title":"Liver metastases of neuroendocrine tumours; early reduction of tumour load to improve life expectancy","volume":"4","author":"Veenendaal","year":"2006","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ando.2025.102463_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms23031447","article-title":"Role of somatostatin signalling in neuroendocrine tumours","volume":"23","author":"Rogoza","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ando.2025.102463_bib0210","doi-asserted-by":"crossref","first-page":"7881","DOI":"10.1038\/s41598-021-86839-2","article-title":"An updated analysis of the epidemiologic trends of neuroendocrine tumors in Taiwan","volume":"11","author":"Chang","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ando.2025.102463_bib0215","doi-asserted-by":"crossref","first-page":"820725","DOI":"10.3389\/fsurg.2022.820725","article-title":"Survival analysis in gastrointestinal neuroendocrine carcinoma with bone metastasis at diagnosis","volume":"9","author":"Chen","year":"2022","journal-title":"Front Surg"},{"key":"10.1016\/j.ando.2025.102463_bib0220","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3892\/mco.2014.332","article-title":"Observational study of patients with gastroenteropancreatic and bronchial neuroendocrine tumors in Argentina: results from the large database of a multidisciplinary group clinical multicenter study","volume":"2","author":"O\u2019Connor","year":"2014","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.ando.2025.102463_bib0225","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12672-018-0354-5","article-title":"Chilean registry for neuroendocrine tumors: a Latin American perspective","volume":"10","author":"Pinto","year":"2019","journal-title":"Horm Cancer"},{"key":"10.1016\/j.ando.2025.102463_bib0230","first-page":"1","article-title":"Neuroendocrine tumors: an analysis of prevalence, incidence, and survival in a hospital-based study in Ecuador","volume":"10","author":"Escobar","year":"2022","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.ando.2025.102463_bib0235","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.rccan.2018.08.001","article-title":"Resultados del tratamiento multidisciplinario de tumores neuroendocrinos de intestino delgado","volume":"22","author":"Fierro-Maya","year":"2018","journal-title":"Rev Colomb Cancerol"},{"key":"10.1016\/j.ando.2025.102463_bib0240","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1590\/S1807-59322011001000002","article-title":"Neuroendocrine tumors involving the gastroenteropancreatic tract: a clinicopathological evaluation of 773 cases","volume":"66","author":"Estrozi","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.ando.2025.102463_bib0245","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1200\/JCO.2022.40.4_suppl.503","article-title":"Neuroendocrine tumors: ten years of experience in a Mexican oncology reference center","volume":"40","author":"Torres-Cisneros","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ando.2025.102463_bib0250","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ando.2025.102463_bib0255","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejca.2022.03.007","article-title":"The European neuroendocrine tumour society registry, a tool to assess the prognosis of neuroendocrine neoplasms","volume":"168","author":"Borbath","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ando.2025.102463_bib0260","first-page":"1","article-title":"Management options for advanced low or intermediate grade gastroenteropancreatic neuroendocrine tumors: review of recent literature","volume":"2017","author":"Neychev","year":"2017","journal-title":"Int J Surg Oncol"},{"key":"10.1016\/j.ando.2025.102463_bib0265","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4240\/wjgs.v13.i3.231","article-title":"Gastroenteropancreatic neuroendocrine neoplasms: a clinical snapshot","volume":"13","author":"Fernandez","year":"2021","journal-title":"World J Gastrointest Surg"},{"key":"10.1016\/j.ando.2025.102463_bib0270","doi-asserted-by":"crossref","DOI":"10.1530\/endoabs.37.GP.28.06","article-title":"Patient-reported time to diagnosis of neuroendocrine tumors (NETs) in Europe: results from the first global NET patient survey. A collaboration between the International Neuroendocrine Cancer Alliance (INCA) and Novartis","author":"Pavel","year":"2015","journal-title":"Endocr Abstr"},{"key":"10.1016\/j.ando.2025.102463_bib0275","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1186\/s12885-018-5057-3","article-title":"Delays and routes to diagnosis of neuroendocrine tumours","volume":"18","author":"Basuroy","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ando.2025.102463_bib0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.rgmx.2024.11.006","article-title":"Tumores neuroendocrinos gastroenteropancre\u00e1ticos: un estudio retrospectivo en el suroccidente colombiano","author":"Bravo-Oca\u00f1a","year":"2025","journal-title":"Rev Gastroenterol M\u00e9xico"},{"key":"10.1016\/j.ando.2025.102463_bib0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers15020439","article-title":"Al[18F]F-NOTA-Octreotide is comparable to [68Ga]Ga-DOTA-TATE for PET\/CT imaging of neuroendocrine tumours in the Latin-American population","volume":"15","author":"Haeger","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ando.2025.102463_bib0290","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/annonc\/mdq022","article-title":"Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE)","volume":"21","author":"Garcia-Carbonero","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ando.2025.102463_bib0295","doi-asserted-by":"crossref","first-page":"e2124750","DOI":"10.1001\/jamanetworkopen.2021.24750","article-title":"Epidemiologic trends of and factors associated with overall survival for patients with gastroenteropancreatic neuroendocrine tumors in the United States","volume":"4","author":"Xu","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ando.2025.102463_bib0300","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.3390\/cancers15184506","article-title":"Survival and response outcomes for gastrointestinal neuroendocrine tumor (GEP-NETs) patients treated with lutetium\u2013177-DOTATATE in a Brazilian reference center: a six-year follow-up experience","volume":"15","author":"de Souza","year":"2023","journal-title":"Cancers (Basel)"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426625007826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426625007826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T01:44:54Z","timestamp":1764985494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426625007826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0003426625007826"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2025.102463","relation":{},"ISSN":["0003-4266"],"issn-type":[{"type":"print","value":"0003-4266"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic factors and survival in gastroenteropancreatic neuroendocrine neoplasm: Real-world evidence from a South American Single-Center Cohort","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2025.102463","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102463"}}